2024 annual financial data
Vertex Pharmaceuticals 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -4.47%.
Operating income was -232,900,000 USD and net income was -535,600,000 USD.
Operating cash flow was -492,600,000 USD.
Get free Vertex Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,020,100,000 USD
- Operating income
- -232,900,000 USD
- Net income
- -535,600,000 USD
- Operating cash flow
- -492,600,000 USD